Cardiovascular disease (CVD) is a major cause of mortality and hospitalization worldwide.
Several risk factors have been identified that are strongly associated with the development …

Background The growing awareness of cardiovascular toxicity from cancer therapies has led
to the emerging field of cardio‐oncology, which centers on preventing, detecting, and …

Cardiovascular diseases (CVDs) are disorders associated with the heart and circulatory
system. Atherosclerosis is its major underlying cause. CVDs are chronic and can remain …

In their day-to-day clinical practice, physicians are facing the adverse effects and limited
effectiveness of currently used drugs in the treatment of major diseases. Biomarkers …

The primary prevention of cardiovascular disease relies on the ability to identify at‐risk
individuals long before the development of overt events. In the past decade, research into …

Objective—Incorporation of novel plasma protein biomarkers may improve current models
for prediction of atherosclerotic cardiovascular disease (ASCVD) risk. Approach and Results …

PURPOSE The incidence of cardiometabolic risk factors in breast cancer (BC) survivors has
not been well described. Thus, we compared risk of hypertension, diabetes, and …

By analogy to the success of cardiovascular medicine in reducing mortality through
preventive measures, cancer chemoprevention has the potential to significantly reduce …

As many novel cancer therapies continue to emerge, the field of Cardio-Oncology (or onco-
cardiology) has become crucial to prevent, monitor and treat cancer therapy-related …

Abstract The European Union multi-disciplinary Personalised RNA interference to Enhance
the Delivery of Individualised Cytotoxic and Targeted therapeutics (PREDICT) consortium …